Search clinical trials for: Poly(ADP-ribose) Polymerase Inhibitors
Total 2213 results
-
Teva Branded Pharmaceutical Products R&D, Inc.Terminated
-
Sun Yat-sen UniversityHutchmedRecruitingOvarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Cancer | Ovarian Carcinoma | Fallopian Tube CarcinosarcomaChina
-
Affiliated Hospital of Jiangnan UniversityRecruitingCarcinoma, Non-Small-Cell Lung | EGF-R Positive Non-Small Cell Lung CancerChina
-
Hellenic Cooperative Oncology GroupActive, not recruitingOvarian CancerGreece
-
Jin LiNot yet recruitingRelapsed Ovarian Cancer
-
Xiaoxiang ChenNot yet recruitingOvarian Cancer | HRD | PARP InhibitorChina
-
Allarity TherapeuticsDanish Breast Cancer Cooperative Group; Smerud Medical Research International...Active, not recruiting
-
Peking University Cancer Hospital & InstituteRecruitingOvarian, Fallopian Tube and Primary Peritoneal CarcinomaChina
-
ETOP IBCSG Partners FoundationGlaxoSmithKline; Development LimitedRecruitingSCLC,Extensive Stage | SLFN11-positiveSwitzerland, France, Spain, Italy
-
University of MalayaPfizer; Cancer Research Malaysia; Pantai Hospital Kuala Lumpur; Hospital Sultan...RecruitingTriple Negative Breast Cancer | HRD 100 Gene Expression HighMalaysia
-
AstraZenecaRecruitingSolid TumoursAustralia, Korea, Republic of, Germany, United States, Spain, France, Canada, Italy, Austria, Israel, United Kingdom, Denmark, Hungary, Poland, Russian Federation, Ukraine, Brazil
-
University of OklahomaGlaxoSmithKlineTerminatedRecurrent Glioblastoma | Recurrent Glioma | Recurrent Astrocytoma | Recurrent OligodendrogliomaUnited States
-
TakedaCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerJapan
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineActive, not recruitingSarcoma,Soft Tissue | Sarcoma UterusUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AstraZenecaActive, not recruiting
-
GlaxoSmithKlineActive, not recruitingBreast Neoplasms | Ovarian NeoplasmsUnited States, Austria, Denmark, Spain, Canada, France, Israel, Italy
-
The Netherlands Cancer InstituteTesaro, Inc.TerminatedBreast CancerNetherlands
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProstate CancerUnited States
-
Hebei Medical University Fourth HospitalNot yet recruiting
-
National Cancer Institute (NCI)RecruitingPancreatic Acinar Cell CarcinomaUnited States
-
Seoul National University HospitalSamsung Medical Center; Takeda; Asan Medical Center; Yonsei UniversityNot yet recruitingOvarian Cancer | Epithelial Ovarian Cancer | Ovarian Cancer Stage IV | Ovarian Cancer Stage III
-
AstraZenecaEnrolling by invitationBreast Cancer | Ovarian CancerItaly, Spain, United States, Canada, Belgium, Denmark, Korea, Republic of, Czechia, Turkey, China, United Kingdom, Taiwan, Brazil, Israel, France, Hungary, Poland, Portugal, Germany, Russian Federation, Bulgaria, Finland, Slovenia, Sw...
-
Zhejiang Cancer HospitalActive, not recruitingEpithelial Ovarian CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
ARCAGY/ GINECO GROUPTesaro, Inc.Completed
-
ARCAGY/ GINECO GROUPAstraZenecaCompletedRelapsed Ovarian Cancers PatientsFrance
-
University of ArizonaActive, not recruiting
-
Kristina LindemannUniversity Hospital of North Norway; Haukeland University Hospital; Sorlandet... and other collaboratorsCompletedOvarian Cancer | Peritoneal CancerNorway
-
Royal Marsden NHS Foundation TrustAstraZenecaUnknownGastric Cancer | Oesophageal Cancer | Gastro-Oesophageal Junction CancerUnited Kingdom
-
Tesaro, Inc.Approved for marketingRecurrent Ovarian Cancer
-
Vejle HospitalAbbottCompletedRecurrent, Epithelial Ovarian CancerDenmark
-
Sichuan UniversityNot yet recruitingLung Cancer | Extensive-stage Small-cell Lung CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityAstraZenecaRecruitingProstate Cancer | Prostate Carcinoma | Metastatic Castration-resistant Prostate CancerChina
-
TakedaRecruiting
-
California Pacific Medical Center Research InstituteTesaro, Inc.; Vanderbilt-Ingram Cancer Center; Huntsman Cancer InstituteRecruitingMetastatic MelanomaUnited States
-
TakedaCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerJapan
-
PfizerIn Expanded Access, treating physicians are the SponsorsAvailableMetastatic Castration-Resistant Prostate Cancer
-
Asan Medical CenterNational Cancer Center, Korea; Samsung Medical Center; Seoul St. Mary's Hospital and other collaboratorsCompletedEpithelial Ovarian CancerKorea, Republic of
-
Zhongda HospitalCompleted
-
AstraZenecaCompletedHER2-ve Metastatic Breast Cancer | Germline BRCA1/2 Mutations | Somatic BRCA1/2 MutationsItaly, Spain, Poland, Taiwan, Canada, France, Germany, Korea, Republic of, Hungary, Japan, Russian Federation, Turkey, United Kingdom, United States, Bulgaria
-
Grupo Español de Investigación en Cáncer de OvarioAstraZeneca; Apices Soluciones S.L.Completed
-
Grupo Español de Investigación en Cáncer de OvarioClovis Oncology, Inc.CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerSpain
-
Tesaro, Inc.Myriad Genetics, Inc.; Facing Our Risk of Cancer EmpoweredCompletedOvarian Neoplasms | Ovarian CancerUnited States, Canada
-
Samsung Medical CenterCompleted
-
Korea University Anam HospitalTakeda; Korean Cancer Study GroupNot yet recruiting
-
The University of Hong KongRecruitingEndometrial CancerHong Kong
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMetastatic Breast Cancer in Germline-PALB2 Mutations Carriers
-
Tianjin Huanhu HospitalRecruiting
-
Royal Marsden NHS Foundation TrustRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomAstraZeneca; Cancer Research UKRecruitingGynaecological CancersUnited Kingdom